Displaying 121 - 130 of 243
Alternative Name: Levonorgestrel Gastric Resident Dosage Form, Levonorgestrel Gastric Retentive Dosage Form
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Oral
Developer: Lyndra Therapeutics, Massachusetts Institute of Technology
Project Stage: Pre-clinical
Alternative Name: Levonorgestrel (LNG) Intracervical Device (ICD)
Active Status: No
User: Female
Mode: Yes
Delivery Type: Vaginal, Other
Developer: University of Helsinki, Population Council
Project Stage: Phase I
Alternative Name: Levonorgestrel (LNG)-only patch; AG890
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Transdermal
Developer: Agile Therapeutics
Project Stage: Phase II
Alternative Name: One-year LNG Single Rod Implant
Active Status: No
User: Female
Mode: Yes
Delivery Type: Subdermal
Developer: CONRAD, FEI Technologies
Project Stage: Phase I
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Injectable, Subdermal
Developer: Orbis Biosciences
Project Stage: Pre-clinical
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Injectable
Developer: FHI 360
Project Stage: Phase I
Alternative Name: (3β,13ξ)-Lup-20(29)-en-3-ol; Clerodol; Monogynol B; Fagarasterol; Farganasterol
Reference target/product: ABHD2
Active Status: Unknown
User: Female, Male
Mode: No
Delivery Type: Oral, Other
Project Stage: Lead Optimization
Active Status: Unknown
User: Female
Mode: Yes
Delivery Type: Intrauterine
Developer: Merck
Project Stage: Phase II
Active Status: Yes
User: Female
Mode: No
Delivery Type: Oral
Developer: CONRAD
Project Stage: Phase II
Active Status: Unknown
User: Female
Mode: No
Delivery Type: Vaginal Ring
Developer: Andromaco
Project Stage: Phase I
Pages
